Literature DB >> 19466658

Evaluation of a new hemostatic agent Ankaferd Blood Stopper in experimental liver laceration.

Kemal Karakaya1, Hamdi B Ucan, Oge Tascilar, Ali U Emre, Guldeniz K Cakmak, Oktay Irkorucu, Handan Ankarali, Mustafa Comert.   

Abstract

INTRODUCTION: Hemorrhage is a leading cause of death after trauma. It is also the major cause of operating room deaths among patients who undergo liver surgery. Various techniques and materials have been attempted to manage bleeding, but a standard method has not been defined yet. We studied the hemostatic effects of Ankaferd Blood Stopper on liver injury in comparison with regenerated oxidized cellulose.
MATERIALS AND METHODS: Thirty Wistar albino rats underwent partial hepatic laceration by scissors. The animals were randomized to the treatment of resected surface with either Ankaferd Blood Stopper (ABS, n = 11) or regenerated oxidized cellulose (Surgicel, n = 9), or were left untreated (controls, n = 10). All the animals were resuscitated with lactated Ringer's solution at 3.3 ml/min/kg to a mean arterial pressure (MAP) of 100 mmHg. Survival time, total blood loss, resuscitation volume, and MAP were recorded for 30 min or until death. The rats that were alive at the end of 30 min were sacrificed with blood withdrawal from catheters.
RESULTS: Rats in the ABS and Surgicel groups survived significantly longer than rats in the control group (p =.0001). There were no significant differences between the ABS and the Surgicel groups in survival (p =.91). Application of ABS and Surgicel was associated with a significant reduction in blood loss compared to controls (p =.008), with no significant differences between active treatment groups (p =.74). The resuscitation volume was not different.
CONCLUSIONS: ABS is as effective as Surgicel in achieving hemostasis following partial liver excision in an experimental rat model.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19466658     DOI: 10.1080/08941930902866246

Source DB:  PubMed          Journal:  J Invest Surg        ISSN: 0894-1939            Impact factor:   2.533


  16 in total

1.  Evaluation of a haemostatic agent in rabbits.

Authors:  Nesrin Turhan; Hasan Bilgili; Ozge Captug; Mevlut Kurt; Ali Shorbagi; Yavuz Beyazit; Ozlem Kar Kurt; Ali Kosar; Ibrahim Celalettin Haznedaroglu
Journal:  Afr J Tradit Complement Altern Med       Date:  2010-10-02

2.  Ability of the ankaferd blood stopper® to prevent parenchymal bleeding in an experimental hepatic trauma model.

Authors:  Erhan Aysan; Hasan Bektas; Feyzullah Ersoz; Serkan Sari; Arslan Kaygusuz; Gulben Erdem Huq
Journal:  Int J Clin Exp Med       Date:  2010-06-30

3.  Plant extract ankaferd blood stopper effect on bond strength.

Authors:  Goksu Trakyali; M Oguz Oztoprak
Journal:  Angle Orthod       Date:  2010-05       Impact factor: 2.079

4.  Demonstration of the histopathological and immunohistochemical effects of a novel hemostatic agent, Ankaferd Blood Stopper, on vascular tissue in a rat aortic bleeding model.

Authors:  Ozer Kandemir; Mustafa Buyukates; Nilufer Onak Kandemir; Erol Aktunc; Aylin Ege Gul; Sanser Gul; S Akin Turan
Journal:  J Cardiothorac Surg       Date:  2010-11-14       Impact factor: 1.637

5.  The Effectiveness of a New Hemostatic Agent (Ankaferd Blood Stopper) for the Control of Bleeding following Tooth Extraction in Hemophilia: A Controlled Clinical Trial.

Authors:  Hakkı Oğuz Kazancıoğlu; Onur Cakır; Gülsüm Ak; Bülent Zülfikar
Journal:  Turk J Haematol       Date:  2013-03-05       Impact factor: 1.831

6.  Experimental investigation of the effects of a blood stopper agent (ankaferd blood stopper) on bone surfaces.

Authors:  Hasan Onur Simşek; Mustafa Şenol Tüzüm; Timuçin Baykul; Inanç Elif Gürer; Cumhur İbrahim Başsorgun
Journal:  Turk J Haematol       Date:  2013-06-05       Impact factor: 1.831

7.  An engineered factor Va prevents bleeding induced by anticoagulant wt activated protein C.

Authors:  Annette von Drygalski; Vikas Bhat; Andrew J Gale; Laurent Burnier; Thomas J Cramer; John H Griffin; Laurent O Mosnier
Journal:  PLoS One       Date:  2014-08-15       Impact factor: 3.240

8.  Effect of the plant-based hemostatic agent Ankaferd Blood Stopper® on the biocompatibility of mineral trioxide aggregate.

Authors:  Muzaffer Emir Dinçol; Hakan Ozbas; Bulent Yılmaz; Handan Ersev; Selcuk Gokyay; Vakur Olgac
Journal:  BMC Oral Health       Date:  2016-10-11       Impact factor: 2.757

9.  Effect of a plant-based hemostatic agent on microleakage of self-etching adhesives.

Authors:  Soley Arslan; Hüseyin Ertaş; Yahya-Orçun Zorba
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2013-01-01

10.  Do blood contamination and haemostatic agents affect microtensile bond strength of dual cured resin cement to dentin?

Authors:  Kerem Kilic; Soley Arslan; Goknil Alkan Demetoglu; Gokmen Zararsiz; Bulent Kesim
Journal:  J Appl Oral Sci       Date:  2013 Jan-Feb       Impact factor: 2.698

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.